PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted full qualification for ...

The liver is the body’s chemical factory, where most metabolic processes take place. It processes everything you eat and drink, converting them into energy and essential nutrients. Additionally, the ...

Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...

This complex liver disorder ranges from simple steatosis to more severe forms ... a pivotal role in controlling key processes such as lipid metabolism, inflammation, apoptosis, and fibrosis in MAFLD.

This complex liver disorder ranges from simple steatosis to more severe ... key processes such as lipid metabolism, inflammation, apoptosis, and fibrosis in MAFLD. Several transcription factors ...

Non-Alcoholic Fatty Liver Disease (NAFLD) is emerging as a significant global health concern, driven by increasing rates of obesity, diabetes and sedentary lifestyles. NAFLD includes a spectrum of ...

However, steatosis can progress ... viruses can cause liver fibrosis without the preceding fatty liver stages. Medications such as non-steroidal anti-inflammatory drugs, anabolic steroids, birth ...

The team revealed distinct phases where waves of immune responses give way to lung fibrosis—scarring of ... of cellular mechanisms underlying inflammatory responses in severe disease.

If left untreated, NAFLD can progress into a more serious form known as non-alcoholic steatohepatitis (NASH), which can cause chronic inflammation, liver scarring, and even liver cancer.

In patients with PSC, nebokitug reduced fibro-inflammatory biomarkers including the enhanced liver fibrosis (ELF) score, PRO-C3, Interleukine-6 (IL-6) and transforming growth factor beta (TGF-β), all ...